Principal Investigator: Michael Eriksen
Funding Mechanism: National Institutes of Health - TCORS Grant
ID number: 1P50DA036128-01
Award Date: 9/30/2013
Institution: Georgia State University
Tobacco companies are rapidly transitioning from combusted products to novel nicotine delivery systems (e.g., e-cigarettes) and alternative tobacco products (e.g., little cigars); however, the actual risk of these products is uncertain, as is whether these products will be used in conjunction with other tobacco products or possibly deter quitting behavior. Investigators will assess use and perceptions of new and emerging tobacco products in a nationally representative sample of adults aged 18 and older. Specific aims are: (1) to assess the patterns of use and perceptions of risk of novel tobacco products and alternative products using quantitative (i.e., annual surveys conducted in years 1 through 5) and qualitative (i.e., six focus groups conducted in years 1, 3 and 5) research methodologies; and (2) to develop and test traditional and new media messages (based on the findings of Aim 1) to improve the quality and accuracy of consumer perceptions of risk, particularly for novel and alternative products. This project will provide new information about risk perceptions, attitudes, and normative beliefs about an array of tobacco products to inform FDA communications and regulations related to these products.